Lawmakers question pricing of Northbrook company’s $89,000 muscular dystrophy drug
Marathon Pharmaceuticals' pricing of a drug to treat genetic muscle deterioration in about 15,000 Americans, mostly boys, is raising concerns in Congress where lawmakers repeatedly have challenged drug companies.Sen. Bernie...